Remove IPO Remove Sale Remove Webinar
article thumbnail

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

On September 24, Cooley M&A partner, Garth Osterman, moderated a webinar on the current trend in going public: SPACs! Key highlights from the webinar are summarized below and a link to the recording can be found here. is the increased frequency at which SPAC IPOs are occurring. A distinct feature of SPAC 3.0

M&A 52
article thumbnail

C Corp vs. S Corp vs. LLC: Essential Information for Software Executives

Software Equity Group

C Corp for Software Companies Factor Impact Investor Appeal Tax Efficiency Ownership Flexibility M&A Potential C Corps are highly attractive to investors, particularly for those considering venture capital or IPO. C Corps are favorable for stock sales, making them ideal for larger exits.

M&A 52
article thumbnail

Cooley’s 2020 Life Sciences M&A Year in Review

Cooley M&A

Divestitures, often achieved through asset sales, were also popular in 2020 as large pharmaceutical companies and biotechnology companies sought to divest noncore assets and focus on core businesses in the wake of economic uncertainty created by the pandemic. Life Sciences Enters the SPAC Party, But Will Reverse Merger Suitors Join In?

M&A 40